These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12051871)

  • 1. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-erbB2 in gestational trophoblastic disease and its clinical significance.
    Wang Y; Cao Y; Sun Y
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):123-5. PubMed ID: 12658752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
    Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
    Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression in human gestational trophoblastic tumors.
    Li F; Shao Z; Cang W; Qian N
    Chin Med J (Engl); 1998 Apr; 111(4):379-80. PubMed ID: 10374410
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of nm23-H1 in hydatidiform mole and its relationship with the development of postmolar disease.
    Iwase K; Okamoto T; Nui R; Mizutani S
    Gynecol Obstet Invest; 2001; 51(4):228-32. PubMed ID: 11408732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.
    Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M
    Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
    Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
    Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
    Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
    Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles.
    Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F
    Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
    Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of nm23-H1 protein in relation to myometrial invasion in complete hydatidiform moles.
    Alex S; Panikkar B; Devi C; Balaram P
    J Soc Gynecol Investig; 2002; 9(2):111-5. PubMed ID: 11963831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44, E-cadherin, and antimetastatic protein nm23-H1 in complete hydatidiform moles.
    Reynolds EA; DuBeshter B; Katzman P; Larson K; Katzel S; Glantz C
    Gynecol Oncol; 2007 Feb; 104(2):451-4. PubMed ID: 17027071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles.
    Shi Z; Zhang T; Long W; Wang X; Zhang X; Ling X; Ding H
    Int J Gynecol Cancer; 2012 Sep; 22(7):1125-9. PubMed ID: 22801034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
    Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
    Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of c-erbB-2 oncogene and p53 tumor suppressor gene with malignant transformation of hydatidiform mole.
    Yazaki-Sun S; Daher S; de Souza Ishigai MM; Alves MT; Mantovani TM; Mattar R
    J Obstet Gynaecol Res; 2006 Jun; 32(3):265-72. PubMed ID: 16764615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
    Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
    Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
    Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.